Addpharma Inc.

This clinical trial is testing whether two experimental oral medications, AD-224A and AD-224B, can safely lower blood pressure in people with essential hypertension (high blood pressure with no known cause). About 254 participants will take one of the drugs or a placebo once dail…

This study tested a new drug called AD-228A in 60 healthy adults to see how it moves through the body compared to taking two separate drugs together. The goal was to check safety and drug levels, not to treat the condition directly. Results will help design future studies for peo…

This early-stage study tests two different forms of a drug for benign prostatic hyperplasia (enlarged prostate) in 44 healthy adult male volunteers. Participants receive a single dose of each version under fasting conditions to compare safety and how the drug moves through the bo…

This early-stage trial is testing a new drug called AD-117, which is being developed for mixed dyslipidemia (abnormal cholesterol levels). The study will give a single dose to 60 healthy adults, either with or without food, to see how food changes the drug's levels in the blood a…

This early-stage study tested a new drug called AD-227 in 70 healthy adults. Researchers wanted to see if taking a single combination tablet works as well as taking two separate pills (AD-227A and AD-227B) in terms of safety and how the drug moves through the body. The study is a…

This early-stage study tested two different tablet versions of a drug for gastric ulcers in 46 healthy adults. Participants received a single dose of each formulation on separate occasions to compare how the drug moves through the body and to check for side effects. The goal is t…